Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients

<p>Demographics and Baseline Characteristics</p>

Сохранить в:

Библиографические подробности
Главный автор:	Cloud P. Paweletz (14960112) (author)
Другие авторы:	Grace A. Heavey (16495683) (author), Yanan Kuang (16495686) (author), Emily Durlacher (16495689) (author), Thian Kheoh (16495692) (author), Richard C. Chao (16495695) (author), Alexander I. Spira (16495698) (author), Konstantinos Leventakos (16495701) (author), Melissa L. Johnson (16019536) (author), Sai-Hong Ignatius Ou (15023025) (author), Gregory J. Riely (14961725) (author), Kenna Anderes (15123501) (author), Wenjing Yang (16495704) (author), James G. Christensen (15123507) (author), Pasi A. Jänne (14954872) (author)
Опубликовано:	2025
Предметы:	Cancer Clinical Research and Trials Methods and Technology Imaging Liquid Biopsy Precision Medicine
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы